Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: A report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†

Medicine & Life Sciences

• Multicenter Studies 100%
• Stents 98%
• Thrombosis 88%
• Extracellular Traps 22%
• Leukocytes 12%
• Eosinophils 10%
• Fibrinogen 10%
• Neutrophils 8%
• Blood Platelets 8%
• Platelet-Rich Fibrin 7%
• Everolimus 6%
• Thrombectomy 6%
• Drug-Eluting Stents 6%
• Sirolimus 5%
• Pathologic Processes 5%
• Hematoxylin 5%
• Percutaneous Coronary Intervention 5%
• Eosine Yellowish-(YS) 5%
• Leukocyte Count 5%
• Metals 4%
• Catheters 4%
• Erythrocytes 4%
• Myocardial Infarction 3%
• Immunohistochemistry 3%
• Control Groups 2%